Inventor · disambiguated record
Andreas Petri
Also filed as: PETRI ANDREAS
18 granted patents·6 pending applications·53 citations·filing 2004–2023
92Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS7MASSACHUSETTS GEN HOSPITAL5NOVOZYMES AS3BETH ISRAEL DEACONESS MEDICAL CT INC2MILTITZ AROMATICS GMBH2
Top patents by PatentIndex Score
24 records- 0192US9879265B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2014·Granted Jan 30, 2018·17 cites·34 claims
- 0290US7851176B2Lipolytic enzyme variantsNOVOZYMES AS·Filed 2008·Granted Dec 14, 2010·2 cites·4 claims
- 0390US7632669B2Lipolytic enzyme variantsNOVOZYMES AS·Filed 2007·Granted Dec 15, 2009·2 cites·18 claims
- 0490US7312062B2Lipolytic enzyme variantsNOVOZYMES AS·Filed 2004·Granted Dec 25, 2007·16 cites·16 claims
- 0587US12421516B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2023·Granted Sep 23, 2025·0 cites·26 claims
- 0682US10626395B2Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Apr 21, 2020·1 cites·24 claims
- 0779US12152241B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Nov 26, 2024·1 cites·17 claims
- 0878US11739332B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Granted Aug 29, 2023·0 cites·21 claims
- 0978US10443058B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Oct 15, 2019·1 cites·10 claims
- 1078US10385342B2Methods of treatment using antisense oligomers and conjugates targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Aug 20, 2019·1 cites·63 claims
- 1178US10370668B2Manufacture of antisense oligomers and conjugates targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Aug 6, 2019·1 cites·45 claims
- 1278US9034837B2Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferonHILDEBRANDT-ERIKSEN ELISABETH S·Filed 2010·Granted May 19, 2015·10 cites·26 claims
- 1375US11091764B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Aug 17, 2021·0 cites·50 claims
- 1472US2022213477A1Therapeutic Targeting of a microRNA to Treat Duchenne Muscular DystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 1571US8679774B2Lipolytic enzyme variantsBOJSEN KIRSTEN·Filed 2010·Granted Mar 25, 2014·0 cites·36 claims
- 1670US10301624B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted May 28, 2019·1 cites·25 claims
- 1767US11236336B2Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Feb 1, 2022·0 cites·29 claims
- 1864US2025122140A1Novel cyclic compounds, and use thereof as perfumesMILTITZ AROMATICS GMBH·Filed 2022·Application pending·0 cites
- 1960US2024262780A1Preparation of an intermediate in the synthesis of 2-cyclododecyl-1-propanolMILTITZ AROMATICS GMBH·Filed 2022·Application pending·0 cites
- 2056US11499152B2Inhibitors of micro-RNA 22BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Nov 15, 2022·0 cites·5 claims
- 2156US2023181613A1Inhibitors of micro-rna 22BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2022·Application pending·0 cites
- 2253US10787665B2Antisense oligomers targeting HOXB-AS3 long non-coding RNAOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Sep 29, 2020·0 cites·16 claims
- 2337US2023348911A1Antisense oligonucleotides for modulation of long noncoding rnasUNIV AALBORG·Filed 2017·Application pending·0 cites
- 2437US2022354888A1ANTISENSE OLIGONUCLEOTIDES (ASOs) DESIGNED TO INHIBIT IMMUNE CHECKPOINT PROTEINSUNIV AALBORG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Petri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →